Showing articles from Genetic Engineering and Biotechnology News

IPO Raises $304M for Caribou, Developer of Gene-Edited Cell ...

Caribou sold 19 million shares at $16 a share—the top of its $14-to-$16 price range. Investors pushed up the share price to $19.17 at 11:57 a.m....

Genetic Engineering and Biotechnology News | 2021-07-26 08:06:01